InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Marshall Patrick. Director active across 1 company, notably Edesa Biotech, Inc.. In total, 2 reports have been published. History available since 12 February 2025. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations